Ocaratuzumab: A New Hope for Autoimmune Diseases? This novel treatment, ocaratuzumab, appears to present significant benefits for individuals affected with various autoimmune conditions. Scientists believe that its unique mechanism of action, modulating certain specific subset of B cells, might efficiently alleviate swelling and modify disease wor

Etaracizumab, formerly referred to as MEDI523 and later LM609, represents a novel method in anti-inflammatory therapy. This engineered antibody is intended to precisely inhibit the activity of complement protein , a vital component of the complement system involved in tissue damage. Research have focused on its possible application in several auto